Antioxidant treatment, especially EUK-207, which is a SOD mimetic, inhibited the progression of tau phosphorylation and, in effect, decreased the disease symptoms in 3X-Tg-AD, an aggressive mouse model of AD [144]. This evidence concerns the gene MAPT and Alzheimer disease.